Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Context Therapeutics Inc. publishes a filing, an earnings call transcript or a press release.

Get CNTX alerts

About Alex Levit

The proxy statement of Context Therapeutics Inc. reports total compensation of $816,671 for Alex Levit in fiscal 2025, including a base salary of $397,807. Disclosed compensation is on record for 5 fiscal years. Context Therapeutics Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Context Therapeutics Inc. includes Martin Lehr (CEO and Board Member), Andy Pasternak (Chairman and Board Member), Jennifer Minai-Azary (CFO) and 7 others.

Affiliation history

Company network

Leadership on record at Context Therapeutics Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Context Therapeutics Inc. (CNTX) $397,807 $816,671
2024 Context Therapeutics Inc. (CNTX) $381,062 $670,653
2023 Context Therapeutics Inc. (CNTX) $369,963 $582,148
2022 Context Therapeutics Inc. (CNTX) $358,750 $653,100
2021 Context Therapeutics Inc. (CNTX) $257,197 $596,709

Recent activity

No call appearances or filed executive changes recorded yet.